S&P 500 7,674 -1.43% Nasdaq 26,180 -2.05% Dow Jones 53,277 -0.85% FTSE 100 10,813 +0.86% DAX 26,058 -1.06% Nikkei 225 65,528 -2.86% Hang Seng 25,514 +0.24% WTI Crude 85.22 -0.71% Gold 4,700 +4.68% US 10-Year Treasury Yield 4.738 +0.30% S&P 500 7,674 -1.43% Nasdaq 26,180 -2.05% Dow Jones 53,277 -0.85% FTSE 100 10,813 +0.86% DAX 26,058 -1.06% Nikkei 225 65,528 -2.86% Hang Seng 25,514 +0.24% WTI Crude 85.22 -0.71% Gold 4,700 +4.68% US 10-Year Treasury Yield 4.738 +0.30%

LATEST

Fast fashion retailer, Shein valuation falls to $27 billion in Hong Kong IPO●Exxon Eyes Shell’s $8 Billion U.S. Chemicals Business●CATL debuts e-commerce platform for direct sales to small buyers, as competition sharpens●Global Market: AI debt boom tests investor appetite as tech bond issuance surges●National debt interest expense has exploded 14% in just 9 months●Meet Flock, the $8 billion startup backed by a16z and Tiger facing growing backlash against surveillance capitalism●American Staffing Association chief economist: The future of work is temporary, and that changes everything about the labor market●The company selling a $3,000 mattress cover that billionaires love wants to become a healthcare company that treats sleep apnea●Fast fashion retailer, Shein valuation falls to $27 billion in Hong Kong IPO●Exxon Eyes Shell’s $8 Billion U.S. Chemicals Business●CATL debuts e-commerce platform for direct sales to small buyers, as competition sharpens●Global Market: AI debt boom tests investor appetite as tech bond issuance surges●National debt interest expense has exploded 14% in just 9 months●Meet Flock, the $8 billion startup backed by a16z and Tiger facing growing backlash against surveillance capitalism●American Staffing Association chief economist: The future of work is temporary, and that changes everything about the labor market●The company selling a $3,000 mattress cover that billionaires love wants to become a healthcare company that treats sleep apnea●

Asia

Aurobindo Pharma US subsidiary Lannett Company LLC faces 4 observations from the USFDA

mint - markets · 1h ago · 🇮🇳 India

Aurobindo Pharma US subsidiary Lannett Company LLC faces 4 observations from the USFDA

Aurobindo Pharma said the US FDA conducted a routine inspection of its wholly owned step-down subsidiary in the US from 17th to 21st August 2026, which concluded with four observations.

Read the full story at mint - markets →

More Asia

CATL debuts e-commerce platform for direct sales to small buyers, as competition sharpens

Business - South China Morning Post · 41m ago

Global Market: AI debt boom tests investor appetite as tech bond issuance surges

Markets-Economic Times · 52m ago

Global Market: Shein valuation falls 70% from peak as Hong Kong IPO targets $1.77 billion

Markets-Economic Times · 55m ago

Urban Company shares surge 7% to 11-month high, rally 16% in 2 sessions. Here are 2 reasons why

Markets-Economic Times · 57m ago